2022 Symposium Agenda
Medicinal Cannabis and Cannabinoid-Based Medicine:
Progress, Policy, and Partnership
Day 1: Thursday, April 21, 2022
2022 CMCR Symposium Awards
8:05-8:40 Daniele Piomelli, PhD, MD (h.c.) - 2022 CMCR Pioneer in Medicinal Cannabis Research Award
This award honors leaders in cannabis and cannabinoid research conducting basic and translational research of cannabinoids, other constituents of cannabis, and the endocannabinoid system. The recipient’s work has led to significant advancements in our understanding of the mechanism and physiological effects of cannabinoids and related compounds.
8:40-9:15 Donald Abrams, MD - 2022 CMCR Award for Advancing Cannabis and Cannabinoids as Therapeutics
This award honors those whose work has led to significant changes in our knowledge of or an expansion to the therapeutic use of cannabis and cannabinoid-based medicines. Recipients come from a diverse array of backgrounds, including drug development, medicine, public policy, and advocacy.
9:15-9:20 5-minute break
2022 Award Recipients: Daniele Piomelli, PhD and Donald Abrams, MD
2019 Award Recipients: Raphael Mechoulam, PhD and Geoffrey Guy, MD
9:55-10:00 5-minute break
CMCR Special Lecture
10:20-10:30 Q&A moderated by Igor Grant, MD
10:30-11:55 Panel discussion and Q&A moderated by Steve Gust, PhD, Advisor to CMCR
The invited Federal stakeholders will discuss future directions in regulatory policy related to medicinal cannabis, funding for medicinal cannabis research, and access to cannabis and cannabinoids for research purposes.
Trelaine Ito, Deputy Appropriations Director and Legislative Assistant to Senator Schatz - "Congressional Actions Related to Cannabis Affecting Research"
David Shurtleff PhD, National Center on Complementary and Integrative Health (NCCIH), NIH - "Cannabinoid Research at NIH"
Cassandra Taylor PhD, Center for Drug Evaluation and Research, FDA - "FDA Role in Regulation of Cannabis"
Rik Kline PhD, Chief, Chemistry and Pharmaceutics Branch, NIDA - "Role of the NIDA Drug Supply Program in Providing Cannabis Products for Research"
11:55-12:00 5-minute break
12:00-1:00 Poster Session - LINK to pre-recorded VIDEOS
Day 2: Friday, April 22, 2022
State of the Science Lecture Series
8:00-8:15 Leah Mayo, PhD - Protective Effects of Elevated Anandamide During Stress Exposure
8:15-8:30 Christine Rabinak, PhD - Cannabinoid Modulation of Corticolimbic Activation to Threat
8:30-8:45 Marcel Bonn-Miller, PhD - Cannabis and PTSD
8:45-8:55 Q&A moderated by Arpi Minassian, PhD
8:55-9:00 5-minute break
9:00-9:15 Michelle Sexton, ND - Cannabis and COVID-19 Infection
9:15-9:30 José Alexandre S. Crippa, MD, PhD - Cannabidiol (CBD) and COVID-19
9:30-9:40 Q&A moderated by Ajay Bharti, MD
9:40-9:55 Deepak D'Souza, MD - Blunting Cannabis Use Disorder by Targeting the Endocannabinoid System
9:55-10:00 Q&A moderated by Giordano de Guglielmo, PharmD, PhD
10:00-10:05 5-minute break
10:05-10:55 Panel discussion and Q&A moderated by Igor Grant, MD
Panelists will be invited to discuss partnerships between universities and the cannabis industry, providing models and exploring synergies.
Panelists: Mahmoud ElSohly PhD, Josh Hoerner PhD, Mark Ware MBBS, MRCP, MSc ICD.D
10:55-11:00 5-minute break
11:00-11:45 Panel discussion and Q&A moderated by Tom Marcotte, PhD
Representatives from DEA-licensed cannabis growers will discuss their early experience and future goals to produce cannabis and cannabinoid-based products for research.
Panelists: Justin Abril (Royal Emerald Pharmaceuticals), Steve Groff MD (Groff North America), George Hodgin MBA (Biopharmaceutical Research Company), Sue Sisley MD (Scottsdale Research Institute)